Objective. With transcranial sonography (TS), it is possible to visualize hyperechoic signals in the substantia nigra (SN) in patients with Parkinson disease (PD). Our objective was to correlate the level of echogenicity in the SN with clinical status in patients with PD. Methods. In our pilot study, using TS, we examined 15 patients with the confirmed presence of PD. Staging of the latest clinical status was evaluated according to the Hoehn and Yahr scale. According to TS, the level of echogenicity was graduated as hypoechogenicity, moderate hyperechogenicity, and severe hyperechogenicity. Results. Of the patients with severe hyperechogenicity (8 patients), 7 had Hoehn and Yahr stage III disease, and 1 had stage II disease. Of the patients with moderate hyperechogenicity (6 patients), 4 had stage II disease; 1 had stage III disease; and 1 had stage I disease. The patient with hypoechogenicity had stage I disease. Statistical analysis showed that there was a significant correlation between the level of echogenicity in the SN and the clinical stage (r = 0.7735; P = .0007). Conclusions. In our pilot study, although only a small number of patients were included, we confirmed the usefulness of TS in the evaluation of PD. Key words: hyperechogenicity; Parkinson disease; transcranial sonography. ranscranial sonography (TS) is an established contemporary diagnostic method widely used in the field of neurology. This procedure allows visualization of several brain structures, and with application of the color Doppler sequence, a noninvasive evaluation of the morphologic characteristics and hemodynamics of the major brain arteries is possible.
ranscranial sonography (TS) is an established contemporary diagnostic method widely used in the field of neurology. This procedure allows visualization of several brain structures, and with application of the color Doppler sequence, a noninvasive evaluation of the morphologic characteristics and hemodynamics of the major brain arteries is possible.
A number of articles have been published concerning the possibility of using TS in the evaluation of Parkinson disease (PD). [1] [2] [3] [4] With the use of B-mode imaging through the transtemporal acoustic window, visualization of the brain stem (especially the mesencephalon) and surrounding structures is possible. The mesencephalon is visualized as a butterfly-shaped, hypoechoic structure, whereas surrounding basilar cisterns and the aqueduct are visualized as hyperechoic structures. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] Because of the possibility of visualizing the mesencephalon on TS, there is an opportunity to evaluate changes in the substantia nigra in patients with PD. In these patients, at the level of the substantia nigra, we can observe hyperechoic structural changes. It is well known that in the course of the degenerative process in PD, there is a hyperproduction of free oxygen radicals, responsible for progressive damage to and destruction of the dopaminergic neurons in the substantia nigra. 13 During this degenerative process, there is a mineral deposition (predominantly iron) in dopaminergic neurons. With continuous enlargement of these mineral deposits in the substantia nigra of the mesencephalon, sonographic detection of a hyperechoic signal is possible. [1] [2] [3] [4] [5] These findings reflect the stage of degeneration. Nigral gliosis has also been reported to be responsible for hyperechogenicity in the substantia nigra, as well as exposure to exotoxins and endotoxins. 3, 4 The aim of this study was to evaluate the level of echogenicity in the substantia nigra in relation to clinical status in patients with PD.
Materials and Methods
In our clinical study, 15 patients were included, including 10 men and 5 women with an average age ± SD of 61 ± 15 years. They underwent a thorough neurologic investigation, with confirmed presence of PD according to the Parkinson's Disease Society of the United Kingdom Brain Bank criteria for the diagnosis of idiopathic PD. 14 All patients were hospitalized at our Clinic of Neurology from September to November 2006 (Table 1) . We obtained approval from our institution's Ethics Committee to perform this study. We offered a detailed description of procedures to our patients, and we obtained informed consent from all patients involved in the study.
The staging of the patients' latest clinical status was evaluated according to the Hoehn and Yahr PD scale in 5 stages. 15 For TS, we used a Toshiba SSH-140A sonography system (Toshiba Medical Systems Co, Ltd, Tokyo, Japan) with a sector probe at a frequency of 2.5 MHz. A transtemporal acoustic window was used with the level of penetration at 12 cm. The level of echogenicity was graduated as hypoechogenicity (absence of echogenicity, normal findings), moderate hyperechogenicity, and severe hyperechogenicity, for which we measured the area of the hyperechogenicity (in square centimeters).
Statistical analysis was performed with the Spearman rank correlation test.
Results
According to the Hoehn and Yahr scale, of the 15 patients, 2 had stage I disease; 5 patients had stage II disease; and 8 patients had stage III disease.
According to the level of echogenicity of the substantia nigra, 1 patient had absence of hyperechogenicity (hypoechogenicity, normal findings; Figure 1) ; 6 patients had moderate hyperechogenicity; and 8 patients had severe hyperechogenicity (Figure 2) . The average area of hyperechogenicity in these 8 patients was 0.30 ± 0.05 cm 2 ( Figure 3 ). (Table 2) .
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According to the statistical analysis, there was a significant correlation between the level of echogenicity in the substantia nigra and the clinical stage (Spearman rank correlation, r = 0.7735; P = .0007).
Discussion
Transcranial sonography is a contemporary diagnostic procedure in neurology. In addition to diagnosis of vascular neurologic disease, this method allows evaluation of patients with PD. This finding is confirmed by a number of studies published in the medical literature. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] To our knowledge, a study that used TS as a diagnostic method for evaluating PD has not been reported previously in our country.
There are other available diagnostic procedures for evaluating PD. With single-photon emission computed tomography and positron emission tomography, it is possible to examine biological changes in metabolism in the nigrostriatal system. 16, 17 However, these methods have an invasive component (contrast application) and are more expensive, so they cannot be used in everyday routines. In contrast, TS is a diagnostic procedure with several advantages: it is a noninvasive, low-cost, repeatable method and is available to patients at bedside.
In our study, although only a small number of patients were included, we confirmed the usefulness of TS in evaluation of PD with regard to the correlation between the level of echogenicity in substantia nigra and the clinical stage of the dis- ease. By measuring the area of hyperechogenicity, it is possible to have a more precise view into the course of PD. 5, 7, 9 In a prospective follow-up clinical study, following patients for several years with regular-interval TS examinations including measurement of the area of echogenicity, we could be able to have a better look into the course of PD itself.
